International Deprescribing Journal Club
About the International Deprescribing Journal Club
The Canadian Medication Appropriateness and Deprescribing Network works with international partners to host the journal club’s quarterly sessions. This journal club is for clinicians and researchers around the globe looking to connect and discuss recent deprescribing publications and complex clinical cases.
Goals of the International Deprescribing Journal Club
Strengthen partnerships among international deprescribing networks
Stay current with the literature and share knowledge
Build momentum and collaboration to facilitate larger international deprescribing trials showing impacts of deprescribing
Session topics & format
Content includes deprescribing case studies, recent literature, or a combination of both
Sessions last approximately 50 to 60 minutes, including a minimum of 20 minutes of Q&A
Sessions are recorded and posted on the Canadian Medication Appropriateness and Deprescribing Network’s YouTube channel.
Upcoming session
Successful Deprescribing in Chronic Pain: Discussions of Two Complex Cases
Date and time: Wednesday, February 26, 2025, 12-1 PM (Montréal, Canada)
Other time zones: Wednesday, February 26, 2025, 9-10 AM (Los Angeles, USA)
Wednesday, February 26, 2025, 5-6 PM (London, UK)
Thursday, February 27, 2025, 4-5 AM (Melbourne, Australia)
Hosted by: Canadian Medication Appropriateness and Deprescribing Network & Quebec Pain Research Network
Description: Using two real-life clinical cases, this session will describe the process of deprescribing or rotating opioids, gabapentinoids and other medication classes. A particular emphasis will be placed on the importance of provider follow-ups, availability of an interprofessional team’s support, and active patient engagement for successful deprescribing interventions.
Presenter: Anne Marie Pinard (MD, MEd) is an anesthesiologist and head of the chronic pain department at the Québec CHU (University Hospital Center). She is a full professor at Laval University and a researcher at Centre interdisciplinaire de recherche en réadaptation et intégration sociale (CIRRIS). She holds the Leadership Chair in Chronic Pain Education, aiming to improve chronic pain management and provide patients with validated resources and a self-management tool. She is very involved in various chronic pain initiatives at the provincial and Canadian levels.
Past sessions
Engaging inpatient clinicians in deprescribing: lessons from an implementation science approach.
Presenter : Michelle Keller, PhD
Moderator : Roni Kraut MD, MSc
Hosted by: US Deprescribing Research Network
Date: December 12th, 2024
Description: Dr. Keller discussed the paper Identifying barriers and facilitators to deprescribing benzodiazepines and sedative hypnotics in the hospital setting using the Theoretical Domains Framework and the Capability, Opportunity, Motivation and Behaviour (COM-B) Model: a qualitative study.
Reducing inappropriate prescribing in older adults: Lessons learned from Swiss primary care settings
Presented by: Dr. Katharina Tabea Jungo
Hosted by: Network of European Researchers in Deprescribing (NERD)
Date: Oct 30, 2024
Dr. Jungo discussed the article Optimising prescribing in older adults with multimorbidity and polypharmacy in primary care (OPTICA): cluster randomised clinical trial, including findings of the health economic analysis and the implementation evaluation conducted alongside the OPTICA trial.
Measurement issues in medication safety: what matters, what data do we have and how do we evaluate cost effectiveness?
Presented by: Dr. Jean Spinks
Hosted by: Australian Deprescribing Network
Date: May 21, 2024
Description: Dr. Spinks discussed the article Activating pharmacists to reduce the frequency of medication-related problems (ACTMed) : a stepped wedge cluster randomised trial.
Prescribing Cascades: Identifying, Managing, and Preventing the Domino Effect
Presented by: Dr. Kieran Dalton and Dr. Lisa McCarthy
Hosted by: European Society of Clinical Pharmacy
Date: March 6, 2024
Description: This session provides an overview of key research to help inform the focus and design of guidance, tools, and interventions to minimise the occurrence of prescribing cascades in patients.
Deprescribing educational framework : challenges for implementation and educational scholarship
Presented by: Dr. Barbara Farrell, Dr. Lalitha Raman-Wilms, and Dr. Cheryl A. Sadowski
Hosted by: Canadian Medication Appropriateness and Deprescribing Network
Date: December 6, 2023
Description: Based on the first international interprofessional deprescribing curricular framework, the lead authors share the highlights and discuss application.
Lessons from a pilot of ALIGN: Aligning Medications with What Matters Most
Presented by: Dr. Ariel Green
Hosted by: US Deprescribing Research Network
Date: September 20, 2023
Description: ALIGN is a pragmatic, pharmacist-led telehealth intervention in primary care to optimize medications for people living with dementia and reduce inappropriate polypharmacy by focusing on what matters most to patients and care partners.
COFRAIL and Deprescribing Inappropriate PPIs Trials
Presented by: Dr. Achim Mortsiefer and Dr. Kristie Weir
Hosted by: Network of European Researchers in Deprescribing
Date: June 19, 2023
Description: Dr. Achim Mortsiefer presented The COFRAIL Cluster Randomized Trial. Dr. Kristie Weir presents Deprescribing Inappropriate PPIs Trial.
Clinical outcomes of sedative deprescribing within RedUSe and implications for practice
Presented by: Dr. Daniel Hoyle
Hosted by: Australian Deprescribing Network
Date: March 28, 2023
Description: This session discussed the RedUSe study published in International Psychogeriatrics, with reference to more contemporary literature/clinical guidelines when discussing the implications of the findings.
Initial findings from the iSIMPATHY project and experiences of implementation
Presented by: iSIMPATHY Project Team
Hosted by: European Society of Clinical Pharmacy
Date: Dec 1, 2022
Description: iSIMPATHY (implementing Stimulating Innovation in the Management of Polypharmacy and Adherence Through the Years) is an EU funded partnership between Ireland, Scotland and Northern Ireland delivering person-centred, pharmacist-led medication reviews across primary and secondary care. Click here to download slides (PDF)
The OPTIMIZE Trial: A Clinician’s Reflection on the Challenges of Deprescribing
Presented by: Louise Papillon-Ferland, B.Pharm., M.Sc.
Hosted by: Canadian Medication Appropriateness and Deprescribing Network
Date: October 5, 2022
Description: This session presented key learnings from the OPTIMIZE trial and discussed enablers and barriers of deprescribing, as applied to real-life clinical cases.
Date: October 5, 2022